{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:19:21Z","timestamp":1771622361638,"version":"3.50.1"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:p>B\u2010cell chronic lymphocytic leukaemia (B\u2010CLL) is characterized by an accumulation of clonal malignant B cells. The intrinsic characteristics that permit this accumulation have been extensively studied and described. However, it is possible that proliferation and survival of this malignant clone is facilitated by a disruption in the interaction between B and T cells that normally regulate the immune system. In this study, using flow cytometry and cell culture techniques, marked abnormalities of the expression of certain key activation and interaction molecules on the peripheral blood T cells of patients with B\u2010CLL were demonstrated. In particular, on comparison with normal controls, there was a marked reduction in the number of circulating T cells expressing CD25 (interleukin 2 receptor) (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7007), CD28 (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b701) and CD152 (CTLA\u20104) (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7001). There was also a reduction in the number of circulating T cells expressing CD4 (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b703), CD5 (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b705) and CD11a (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b701). There was no difference in the number expressing T\u2010cell receptor \u03b1\u03b2 (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b71), CD8 (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b74), CD54 (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b74) and CD154 (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b75), and the only marker expressed on a greater number of circulating T cells in B\u2010CLL patients was HLA\u2010DR (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b705). These results suggest that there is a profound T\u2010cell dysregulation that may contribute to the survival of the malignant B cells in patients with B\u2010CLL and to the related autoimmune phenomena of the disease.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02672.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:32:45Z","timestamp":1047364365000},"page":"959-964","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Analysis of the expression of critical activation\/interaction markers on peripheral blood T cells in B\u2010cell chronic lymphocytic leukaemia: evidence of immune dysregulation"],"prefix":"10.1111","volume":"112","author":[{"given":"Sophie","family":"Scrivener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward R.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Demaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archie G.","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/72323"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309148516"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.V67.2.279.279","article-title":"Defective interleukin\u20102 production and responsiveness to T ce.lls in patients with chronic lymphocytic leukaemia of B cell variety","volume":"67","author":"Ayanlar\u2010Batuman O.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_6_5_1","first-page":"199","volume-title":"Immunology, a Short Course","author":"Benjamini E.","year":"1996"},{"key":"e_1_2_6_6_1","first-page":"435","article-title":"Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3","volume":"15","author":"Bonnefoy\u2010Berard N.","year":"1996","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03189355"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0997-984"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.122.3.1087","article-title":"T cell helper defect in patients with chronic lymphocytic leukaemia","volume":"122","author":"Chiorazzi N.","year":"1979","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60854-8"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.V83.8.2198.2198","article-title":"Expansion of T cells expressing low CD4 or CD8 levels in B\u2010cell chronic lymphocytic leukaemia: correlation with disease status and neoplastic phenotype","volume":"83","author":"Dianzani U.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90269-0"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(90)90112-M"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood.V66.3.614.614","article-title":"Interleukin\u20102 (IL 2) and interferon\u2010\u03b3 production by T lymphocytes from patients with B\u2010chronic lymphocytic leukaemia: evidence that normally released IL\u20102 is absorbed by the neoplastic B cell population","volume":"66","author":"Foa R.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(96)10030-x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02786323"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood.V58.6.1182.1182","article-title":"Defective immunoregulatory in T\u2010cell function in chronic lymphocytic leukaemia","volume":"58","author":"Han T.","year":"1981","journal-title":"Blood"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00944.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.V57.3.418.418","article-title":"Abnormal T\u2010cell subpopulation function in CLL: excessive suppressor (T\u03b3) and deficient helper (T\u03bc) activity with respect to B\u2010cell proliferation","volume":"57","author":"Kay N.","year":"1981","journal-title":"Blood"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood.V54.2.540.540","article-title":"T\u2010cell subpopulations in chronic lymphocytic leukaemia: abnormalities in distribution and in vitro receptor maturation","volume":"54","author":"Kay N.","year":"1979","journal-title":"Blood"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.2.459"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.233"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(95)80031-X"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(89)90039-X"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2107.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1182\/blood.V78.6.1569.1569","article-title":"Decreased CD45RA T cells in B\u2010cell chronic lymphatic leukaemia patients: correlation with disease stage","volume":"78","author":"Peller S.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_27_1","first-page":"1563","article-title":"Diminished DNA synthesis in T cells from B chronic lymphocytic leukaemia after phytohaemagglutinin, anti\u2010CD3 and phorbol myristate acetate mitogenic signals","volume":"21","author":"Prieto A.","year":"1993","journal-title":"Experimental Hematology"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-2478(97)00092-8"},{"key":"e_1_2_6_29_1","first-page":"494","article-title":"Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukaemia","volume":"10","author":"Rossi E.","year":"1996","journal-title":"Leukaemia"},{"key":"e_1_2_6_30_1","first-page":"33","article-title":"The complexity of the B7\u2013CD28\/CTLA\u20104 co\u2010 stimulatory pathway","volume":"49","author":"Schweitzer A.N.","year":"1998","journal-title":"Agents and Actions Supplements"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483x(95)03123-w"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90152-G"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1182\/blood.V91.11.4273","article-title":"Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo\u20101\/CD95) ligand tumour cells in B chronic lymphocytic leukaemia","volume":"91","author":"Tinhofer I.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90125-6"},{"key":"e_1_2_6_35_1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood.V74.2.786.786","article-title":"T\u2010cell activation and subset patterns are altered in B\u2010CLL and correlate with the stage of the disease","volume":"2","author":"Totterman T.H.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3008337"},{"key":"e_1_2_6_37_1","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/S0021-9258(18)49895-X","article-title":"The Interleukin\u20102 receptor","volume":"266","author":"Waldmann T.","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(94)90071-X"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02672.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02672.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02672.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T16:07:10Z","timestamp":1695830830000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02672.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02672.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02672.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}